D-1036-2016 Class III Terminated
FDA drug recall D-1036-2016 was initiated by Sandoz Inc on May 25, 2016 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Package Insert The recall status is terminated (terminated Apr 25, 2017). Affected quantity: 3,048 bottles ( 304,800 tablets).
Recall details
- Product Type
- Drugs
- Report Date
- Jun 22, 2016
- Initiation Date
- May 25, 2016
- Termination Date
- Apr 25, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,048 bottles ( 304,800 tablets)
Product description
Lisinopril Tablets USP, 30 mg, 100-count bottle, Rx Only, Manufactured by Sandoz Inc., Princeton, NJ 08540, NDC 0185-0630-01
Reason for recall
Labeling: Incorrect or Missing Package Insert
Distribution pattern
Nationwide
Code information
Lot # FC1960; Exp.: 02/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1036-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026